N~2~-(3-aminopropyl)-N-[(4-fluorophenyl)methyl]-N~2~-(2-phenylethyl)-N-[2-(4-sulfamoylphenyl)ethyl]glycinamide

InChIKey	`PTOFZDQATQXAPS-UHFFFAOYSA-N`
Compound Name	N~2~-(3-aminopropyl)-N-[(4-fluorophenyl)methyl]-N~2~-(2-phenylethyl)-N-[2-(4-sulfamoylphenyl)ethyl]glycinamide
Canonical SMILES	`NCCCN(CCc1ccccc1)CC(=O)N(CCc1ccc(S(N)(=O)=O)cc1)Cc1ccc(F)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	7.38
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43570	CA12	Homo sapiens	Human	PF00194	9.2	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	7.5	Ki	ChEMBL;BindingDB
P22748	CA4	Homo sapiens	Human	PF00194	6.4	Ki	ChEMBL;BindingDB
P00915	CA1	Homo sapiens	Human	PF00194	6.3	Ki	ChEMBL;BindingDB